Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ruprecht

Showing results (151-160 of 207) with videos related to

Pageof 21
Sort By:
AIDS Research and Human Retroviruses|May 20, 1997
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulinsA Li, T W Baba, J Sodroski, et al.
AIDS (London, England)|May 16, 2018
Anti-HIV IgM protects against mucosal SHIV transmissionSiqi Gong, Khamis Tomusange, Viraj Kulkarni, et al.
Journal of Medical Primatology|April 24, 2010
AIDS and optic neuritis in a rhesus monkey infected with the R5 clade C SHIV-1157ipd3N4Anapatricia García, Nagadenahalli B Siddappa, Qingsheng Li, et al.
Vaccine|November 13, 2010
A live attenuated Listeria monocytogenes vaccine vector expressing SIV Gag is safe and immunogenic in macaques and can be administered repeatedlyGaia Sciaranghella, Samir K Lakhashe, Mila Ayash-Rashkovsky, et al.
AIDS Research and Human Retroviruses|May 15, 1998
Oral SIV, SHIV, and HIV type 1 infectionR M Ruprecht, T W Baba, V Liska, et al.
Trials|October 19, 2021
Optimization of sepsis therapy based on patient-specific digital precision diagnostics using next generation sequencing (DigiSep-Trial)-study protocol for a randomized, controlled, interventional, open-label, multicenter trialThorsten Brenner, Annabell Skarabis, Philip Stevens, et al.
AIDS (London, England)|January 31, 2003
Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaquesFlavia Ferrantelli, Regina Hofmann-Lehmann, Robert A Rasmussen, et al.
AIDS Research and Human Retroviruses|June 27, 2006
Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaquesAgneta S von Gegerfelt, Candido Alicea, Antonio Valentin, et al.
AIDS (London, England)|June 19, 2013
Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmissionJennifer D Watkins, Anton M Sholukh, Muhammad M Mukhtar, et al.
Plos One|September 13, 2012
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41Mei-Yun Zhang, Tingting Yuan, Jingjing Li, et al.
Pageof 21

Showing results (151-160 of 207) with videos related to

Sort By:
Pageof 21
AIDS Research and Human Retroviruses|May 20, 1997
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulinsA Li, T W Baba, J Sodroski, et al.
AIDS (London, England)|May 16, 2018
Anti-HIV IgM protects against mucosal SHIV transmissionSiqi Gong, Khamis Tomusange, Viraj Kulkarni, et al.
Journal of Medical Primatology|April 24, 2010
AIDS and optic neuritis in a rhesus monkey infected with the R5 clade C SHIV-1157ipd3N4Anapatricia García, Nagadenahalli B Siddappa, Qingsheng Li, et al.
Vaccine|November 13, 2010
A live attenuated Listeria monocytogenes vaccine vector expressing SIV Gag is safe and immunogenic in macaques and can be administered repeatedlyGaia Sciaranghella, Samir K Lakhashe, Mila Ayash-Rashkovsky, et al.
AIDS Research and Human Retroviruses|May 15, 1998
Oral SIV, SHIV, and HIV type 1 infectionR M Ruprecht, T W Baba, V Liska, et al.
Trials|October 19, 2021
Optimization of sepsis therapy based on patient-specific digital precision diagnostics using next generation sequencing (DigiSep-Trial)-study protocol for a randomized, controlled, interventional, open-label, multicenter trialThorsten Brenner, Annabell Skarabis, Philip Stevens, et al.
AIDS (London, England)|January 31, 2003
Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaquesFlavia Ferrantelli, Regina Hofmann-Lehmann, Robert A Rasmussen, et al.
AIDS Research and Human Retroviruses|June 27, 2006
Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaquesAgneta S von Gegerfelt, Candido Alicea, Antonio Valentin, et al.
AIDS (London, England)|June 19, 2013
Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmissionJennifer D Watkins, Anton M Sholukh, Muhammad M Mukhtar, et al.
Plos One|September 13, 2012
Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41Mei-Yun Zhang, Tingting Yuan, Jingjing Li, et al.
Pageof 21